# MK0462 in Treatment of Migraine With Recurrence (MK0462-022)

> **NCT00897949** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1473 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** rizatriptan benzoate (MK0462)
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00897949
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-03
- **Primary completion:** 1996-01
- **Final completion:** 1996-07
- **Target enrollment:** 1473 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00897949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00897949, "MK0462 in Treatment of Migraine With Recurrence (MK0462-022)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00897949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*